Ralaniten (EPI-002) is a potent and orally active antagonist of the androgen receptor-N-terminal domain (AR-NTD). Ralaniten inhibits AR transcriptional activity, with IC50 of 7.4 µM. Ralaniten can be used for the research of castration-resistant prostate cancer (CRPC)[1][2].
Molecular Weight:
394.89
Purity:
99.78
CAS Number:
[1203490-23-6]
Formula:
C21H27ClO5
Target:
Androgen Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted